stage IV childhood liver cancer
Showing 1 - 25 of >10,000
Liver Metastasis Colon Cancer Trial (IRE plus checkpoint inhibitor, IRE plus Checkpoint Inhibitor plus CpG-ODN)
Not yet recruiting
- Liver Metastasis Colon Cancer
- IRE plus checkpoint inhibitor
- IRE plus Checkpoint Inhibitor plus CpG-ODN
- (no location specified)
Sep 13, 2023
Liver Transplant Disorder, Hepatic Cancer Trial (assisted liver transplantation combined with two-stage hepatectomy)
Not yet recruiting
- Liver Transplant Disorder
- Hepatic Cancer
- assisted liver transplantation combined with two-stage hepatectomy
- (no location specified)
Mar 6, 2023
Malignant Female Reproductive System Tumor, Stage III Cervical Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8 Trial in Duarte
Not yet recruiting
- Malignant Female Reproductive System Neoplasm
- +10 more
- Discussion
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 24, 2023
Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical
Not yet recruiting
- Clinical Stage II Esophageal Adenocarcinoma AJCC v8
- +11 more
- Acupressure Therapy
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 12, 2023
Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Tumors Germ Cell and Embryonal Tumors by Histologic Type Tumors Tumors
Not yet recruiting
- Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms
- HX008 + TACE
- +2 more
-
Beijing, Beijing, ChinaBeijing Cancer hospital
Dec 8, 2022
Stage, Colon Cancer, Stage I-III Colon Cancer, Stage IV Colon Cancer With Resectable Liver Metastases Trial in Boston (Vitamin
Recruiting
- Stage, Colon Cancer
- +2 more
- Vitamin D3
- Placebo
-
Boston, MassachusettsDana-Farber Cancer Institute
May 18, 2022
Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)
Not yet recruiting
- Ovarian Cancer
- Carboplatin
- olaparibp, embro
-
Birmingham, AlabamaO'Neal Comprehensive Cancer Center at UAB
Jul 18, 2023
Non Small Cell Lung Cancer Metastatic Trial (MRI)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- MRI
- (no location specified)
May 16, 2023
Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7
Active, not recruiting
- Stage III Fallopian Tube Cancer AJCC v7
- +14 more
- Epacadostat
- +2 more
-
Minneapolis, Minnesota
- +1 more
Jan 27, 2023
Colorectal Cancer Trial in Guangzhou (FOLFOX , FOLFIRI or FOLFOXIRI regimens, FOLFOX regimen)
Not yet recruiting
- Colorectal Cancer
- FOLFOX , FOLFIRI or FOLFOXIRI regimens
- FOLFOX regimen
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Apr 26, 2023
LIver, Biliary tRAct and pancReatic Cancers
Recruiting
- Liver Cancer
- +2 more
- Blood drawing
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital, Zhejiang University School of Me
Nov 14, 2023
Stage I Colorectal Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8, Stage IIA Colorectal Cancer AJCC v8 Trial in San
Completed
- Stage I Colorectal Cancer AJCC v8
- +12 more
- Dietary Intervention
-
San Francisco, CaliforniaZuckerberg San Francisco General Hospital
Jan 5, 2023
NSCLC (NSCLC), Stage IV Trial in Switzerland (Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy),
Not yet recruiting
- Non-small Cell Lung Cancer (NSCLC)
- Stage IV
- Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy)
- +2 more
-
Aarau, Switzerland
- +7 more
Oct 27, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver Trial in Atlanta
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +3 more
- Y-90 SIR-Spheres
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jun 7, 2022
Radiomics, Hepatocellular Carcinoma (HCC), Transcatheter Arterial Chemoembolization (TACE) Trial in Guangzhou (Sorafenib,
Active, not recruiting
- Radiomics
- +4 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Jun 5, 2023
Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Tumor Trial in Los Angeles (Biospecimen
Recruiting
- Advanced Cholangiocarcinoma
- +6 more
- Biospecimen Collection
- +3 more
-
Los Angeles, California
- +1 more
Mar 31, 2023
Metastatic Carcinoma in the Liver, Resectable Mass, Stage IV Colorectal Cancer AJCC v7 Trial in Houston (biological, other,
Completed
- Metastatic Carcinoma in the Liver
- +4 more
- Durvalumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 30, 2023
Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)
Active, not recruiting
- Metastatic Liver Carcinoma
- +3 more
- Angiography
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)
Recruiting
- EGFR NP_005219.2:p.S492R
- +7 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Resectable Colorectal Carcinoma Trial in Houston
Recruiting
- Metastatic Colorectal Carcinoma
- +6 more
- Diffusion Weighted Imaging
-
Houston, TexasM D Anderson Cancer Center
Jul 15, 2022
Advanced Lung Carcinoma, Malignant Female Reproductive System Tumor, Stage III Lung Cancer AJCC v8 Trial in Duarte (Psychosocial
Active, not recruiting
- Advanced Lung Carcinoma
- +6 more
- Psychosocial Care Conquer Fear Support intervention (psychoeducation, attention training, worry management, and detached mindfulness components)
- Questionnaire Administration
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Change in Mood, Change in Personality Trial in Haskovo (Undenatured beta-glucan solution, Placebo)
Recruiting
- Change in Mood
- Change in Personality
- Undenatured beta-glucan solution
- Placebo
-
Haskovo, BulgariaCLINECA EAD Hospital
Jul 18, 2023
HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle
Active, not recruiting
- HER2-positive Breast Cancer
- +8 more
- pNGVL3-hICD vaccine
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022